KemPharm

Developers partner to deliver non-additive ADHD drug

Wednesday, April 27, 2011

New Jersey-based MonoSol Rx, the developer of PharmFilm drug delivery technology, has entered into a development and commercialization partnership with Iowa-based KemPharm, a biopharmaceutical company focused on the discovery and development of new, safer therapies for the treatment of attention deficit hyperactivity disorder (ADHD), pain, and cardiovascular disease, according to FierceDrugDelivery.

[Read More]